2020
DOI: 10.21886/2712-8156-2020-1-1-84-90
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Thiotriazoline on Energy Production in Conditions of Chronic Myocardial Ischemia

Abstract: Цель: изучить молекулярные эффекты тиотриазолина у пациентов с ишемической болезнью сердца (ИБС). Материалы и методы: у 60 пациентов со стабильной стенокардией напряжения I-III функционального класса сравнивались эффекты тиотриазолина со стандартным режимом терапии (СРТ), учитывая активность уровня основных продуктов свободнорадикального окисления (СРО) и антиоксидантных систем (АОС), протеомный профиль белков. Результаты: через 24 недели на фоне СРТ и тиотриазолина выявлено статистически достоверное увеличени… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 4 publications
0
3
0
Order By: Relevance
“…In addition, we suggest that Thiotriazoline itself can be a NO carrier, forming stable S-nitrosyl complexes with it [59]. Thiotriazoline exhibits a cardioprotective effect, positively affecting energy metabolism in ischemic myocardium, increases ATP during ischemia and hypoxia due to the normalization of the Krebs cycle, increases the utilization of glucose and free fatty acids, and activates the conversion of lactate to pyruvate [60]. Thiotriazoline is also known to exhibit a cardioprotective effect and to increase the endurance of animals under working hypoxia by increasing HIF-1 and preserving mitochondrial ultrastructure.…”
Section: Discussionmentioning
confidence: 92%
“…In addition, we suggest that Thiotriazoline itself can be a NO carrier, forming stable S-nitrosyl complexes with it [59]. Thiotriazoline exhibits a cardioprotective effect, positively affecting energy metabolism in ischemic myocardium, increases ATP during ischemia and hypoxia due to the normalization of the Krebs cycle, increases the utilization of glucose and free fatty acids, and activates the conversion of lactate to pyruvate [60]. Thiotriazoline is also known to exhibit a cardioprotective effect and to increase the endurance of animals under working hypoxia by increasing HIF-1 and preserving mitochondrial ultrastructure.…”
Section: Discussionmentioning
confidence: 92%
“…The pharmacological effect of the combination is due to a positive effect on the synthesis, transport, and bioavailability of NO and physiological functions of this molecular messenger [44]. In rats in which isadrin-pituitrin myocardial infarction was modeled, Thiotriazoline stimulated LDH in the direction of the formation of pyruvate from lactate, which eliminated lactic acidosis and normalized intracellular pH, and stimulated the Krebs cycle by increasing pyruvate [45]. In the same experimental mode, Thiotriazoline activated the malate-aspartate shunt in the myocardium in the acute period of myocardial infarction.…”
Section: Discussionmentioning
confidence: 99%
“…Thiotriazoline (morpholinium 3-methyl-1,2,4-triazolyl-5thioacet) is a specific scavenger of NO and its cytotoxic forms, increases the bioavailability of NO, protecting it from ROS. Thiotriazoline under conditions of ischemia enhances the compensatory activation of the malate-aspartate shuttle mechanism, reduces the inhibition of oxidation processes in the Krebs cycle while maintaining the intracellular ATP pool, exhibits hepato-, cardioprotective, anti-ischemic and antioxidant properties [10,11,12].…”
Section: Introductionmentioning
confidence: 99%